United States Human Immunoglobulin (pH4) for Intravenous Injection Market Report 2016

December 2016 | 112 pages | ID: U54C596715DEN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Human Immunoglobulin (pH4) for Intravenous Injection

Revenue, means the sales value of Human Immunoglobulin (pH4) for Intravenous Injection

This report studies sales (consumption) of Human Immunoglobulin (pH4) for Intravenous Injection in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Baxter
• CSL
• Bayer
• Grifols
• Octapharma
• Shanghai RAAS
• Hualan Biological
• China Biologic
• Tiantan Biologic
• Shuanglin Bio-pharmacy
• Sichuan Yuanda Shuyang
• Boya Bio-pharmaceutical
• Shanghai Institute of Biological

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• 5g/Bottle Human Immunoglobulin (pH4) for Intravenous Injection (pH4) for Intravenous Injection
• 2.5g/Bottle Human Immunoglobulin (pH4) for Intravenous Injection (pH4) for Intravenous Injection
• 1.25g/Bottle Human Immunoglobulin (pH4) for Intravenous Injection (pH4) for Intravenous Injection

Split by applications, this report focuses on sales, market share and growth rate of Human Immunoglobulin (pH4) for Intravenous Injection in each application, can be divided into

• Primary Immunodeficiency Disease
• Immune-mediated Thrombocytopenia
• Kawasaki Disease
• B Chroniclymphocytic Leukemia(B-CLL)

Contents

United States Human Immunoglobulin (pH4) for Intravenous Injection Market Report 2016

1 HUMAN IMMUNOGLOBULIN (PH4) FOR INTRAVENOUS INJECTION OVERVIEW

1.1 Product Overview and Scope of Human Immunoglobulin (pH4) for Intravenous Injection
1.2 Classification of Human Immunoglobulin (pH4) for Intravenous Injection
  1.2.1 5g/Bottle Human Immunoglobulin (pH4) for Intravenous Injection (pH4) for Intravenous Injection
  1.2.2 2.5g/Bottle Human Immunoglobulin (pH4) for Intravenous Injection (pH4) for Intravenous Injection
  1.2.3 1.25g/Bottle Human Immunoglobulin (pH4) for Intravenous Injection (pH4) for Intravenous Injection
1.3 Application of Human Immunoglobulin (pH4) for Intravenous Injection
  1.3.1 Primary Immunodeficiency Disease
  1.3.2 Immune-mediated Thrombocytopenia
  1.3.3 Kawasaki Disease
  1.3.4 B Chroniclymphocytic Leukemia(B-CLL)
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Human Immunoglobulin (pH4) for Intravenous Injection (2011-2021)
  1.4.1 United States Human Immunoglobulin (pH4) for Intravenous Injection Sales and Growth Rate (2011-2021)
  1.4.2 United States Human Immunoglobulin (pH4) for Intravenous Injection Revenue and Growth Rate (2011-2021)

2 UNITED STATES HUMAN IMMUNOGLOBULIN (PH4) FOR INTRAVENOUS INJECTION COMPETITION BY MANUFACTURERS

2.1 United States Human Immunoglobulin (pH4) for Intravenous Injection Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Human Immunoglobulin (pH4) for Intravenous Injection Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Human Immunoglobulin (pH4) for Intravenous Injection Average Price by Manufactures (2015 and 2016)
2.4 Human Immunoglobulin (pH4) for Intravenous Injection Market Competitive Situation and Trends
  2.4.1 Human Immunoglobulin (pH4) for Intravenous Injection Market Concentration Rate
  2.4.2 Human Immunoglobulin (pH4) for Intravenous Injection Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES HUMAN IMMUNOGLOBULIN (PH4) FOR INTRAVENOUS INJECTION SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 United States Human Immunoglobulin (pH4) for Intravenous Injection Sales and Market Share by Type (2011-2016)
3.2 United States Human Immunoglobulin (pH4) for Intravenous Injection Revenue and Market Share by Type (2011-2016)
3.3 United States Human Immunoglobulin (pH4) for Intravenous Injection Price by Type (2011-2016)
3.4 United States Human Immunoglobulin (pH4) for Intravenous Injection Sales Growth Rate by Type (2011-2016)

4 UNITED STATES HUMAN IMMUNOGLOBULIN (PH4) FOR INTRAVENOUS INJECTION SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 United States Human Immunoglobulin (pH4) for Intravenous Injection Sales and Market Share by Application (2011-2016)
4.2 United States Human Immunoglobulin (pH4) for Intravenous Injection Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 UNITED STATES HUMAN IMMUNOGLOBULIN (PH4) FOR INTRAVENOUS INJECTION MANUFACTURERS PROFILES/ANALYSIS

5.1 Baxter
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Human Immunoglobulin (pH4) for Intravenous Injection Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 Baxter Human Immunoglobulin (pH4) for Intravenous Injection Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 CSL
  5.2.2 Human Immunoglobulin (pH4) for Intravenous Injection Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 CSL Human Immunoglobulin (pH4) for Intravenous Injection Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 Bayer
  5.3.2 Human Immunoglobulin (pH4) for Intravenous Injection Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 Bayer Human Immunoglobulin (pH4) for Intravenous Injection Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 Grifols
  5.4.2 Human Immunoglobulin (pH4) for Intravenous Injection Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 Grifols Human Immunoglobulin (pH4) for Intravenous Injection Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview
5.5 Octapharma
  5.5.2 Human Immunoglobulin (pH4) for Intravenous Injection Product Type, Application and Specification
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 Octapharma Human Immunoglobulin (pH4) for Intravenous Injection Sales, Revenue, Price and Gross Margin (2011-2016)
  5.5.4 Main Business/Business Overview
5.6 Shanghai RAAS
  5.6.2 Human Immunoglobulin (pH4) for Intravenous Injection Product Type, Application and Specification
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 Shanghai RAAS Human Immunoglobulin (pH4) for Intravenous Injection Sales, Revenue, Price and Gross Margin (2011-2016)
  5.6.4 Main Business/Business Overview
5.7 Hualan Biological
  5.7.2 Human Immunoglobulin (pH4) for Intravenous Injection Product Type, Application and Specification
    5.7.2.1 Type I
    5.7.2.2 Type II
  5.7.3 Hualan Biological Human Immunoglobulin (pH4) for Intravenous Injection Sales, Revenue, Price and Gross Margin (2011-2016)
  5.7.4 Main Business/Business Overview
5.8 China Biologic
  5.8.2 Human Immunoglobulin (pH4) for Intravenous Injection Product Type, Application and Specification
    5.8.2.1 Type I
    5.8.2.2 Type II
  5.8.3 China Biologic Human Immunoglobulin (pH4) for Intravenous Injection Sales, Revenue, Price and Gross Margin (2011-2016)
  5.8.4 Main Business/Business Overview
5.9 Tiantan Biologic
  5.9.2 Human Immunoglobulin (pH4) for Intravenous Injection Product Type, Application and Specification
    5.9.2.1 Type I
    5.9.2.2 Type II
  5.9.3 Tiantan Biologic Human Immunoglobulin (pH4) for Intravenous Injection Sales, Revenue, Price and Gross Margin (2011-2016)
  5.9.4 Main Business/Business Overview
5.10 Shuanglin Bio-pharmacy
  5.10.2 Human Immunoglobulin (pH4) for Intravenous Injection Product Type, Application and Specification
    5.10.2.1 Type I
    5.10.2.2 Type II
  5.10.3 Shuanglin Bio-pharmacy Human Immunoglobulin (pH4) for Intravenous Injection Sales, Revenue, Price and Gross Margin (2011-2016)
  5.10.4 Main Business/Business Overview
5.11 Sichuan Yuanda Shuyang
5.12 Boya Bio-pharmaceutical
5.13 Shanghai Institute of Biological

6 HUMAN IMMUNOGLOBULIN (PH4) FOR INTRAVENOUS INJECTION MANUFACTURING COST ANALYSIS

6.1 Human Immunoglobulin (pH4) for Intravenous Injection Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Human Immunoglobulin (pH4) for Intravenous Injection

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Human Immunoglobulin (pH4) for Intravenous Injection Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Human Immunoglobulin (pH4) for Intravenous Injection Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 UNITED STATES HUMAN IMMUNOGLOBULIN (PH4) FOR INTRAVENOUS INJECTION MARKET FORECAST (2016-2021)

10.1 United States Human Immunoglobulin (pH4) for Intravenous Injection Sales, Revenue Forecast (2016-2021)
10.2 United States Human Immunoglobulin (pH4) for Intravenous Injection Sales Forecast by Type (2016-2021)
10.3 United States Human Immunoglobulin (pH4) for Intravenous Injection Sales Forecast by Application (2016-2021)
10.4 Human Immunoglobulin (pH4) for Intravenous Injection Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Disclosure Section
Research Methodology
Data Source
Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Human Immunoglobulin (pH4) for Intravenous Injection
Table Classification of Human Immunoglobulin (pH4) for Intravenous Injection
Figure United States Sales Market Share of Human Immunoglobulin (pH4) for Intravenous Injection by Type in 2015
Figure 5g/Bottle Human Immunoglobulin (pH4) for Intravenous Injection (pH4) for Intravenous Injection Picture
Figure 2.5g/Bottle Human Immunoglobulin (pH4) for Intravenous Injection (pH4) for Intravenous Injection Picture
Figure 1.25g/Bottle Human Immunoglobulin (pH4) for Intravenous Injection (pH4) for Intravenous Injection Picture
Table Application of Human Immunoglobulin (pH4) for Intravenous Injection
Figure United States Sales Market Share of Human Immunoglobulin (pH4) for Intravenous Injection by Application in 2015
Figure Primary Immunodeficiency Disease Examples
Figure Immune-mediated Thrombocytopenia Examples
Figure Kawasaki Disease Examples
Figure B Chroniclymphocytic Leukemia(B-CLL) Examples
Figure United States Human Immunoglobulin (pH4) for Intravenous Injection Sales and Growth Rate (2011-2021)
Figure United States Human Immunoglobulin (pH4) for Intravenous Injection Revenue and Growth Rate (2011-2021)
Table United States Human Immunoglobulin (pH4) for Intravenous Injection Sales of Key Manufacturers (2015 and 2016)
Table United States Human Immunoglobulin (pH4) for Intravenous Injection Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Human Immunoglobulin (pH4) for Intravenous Injection Sales Share by Manufacturers
Figure 2016 Human Immunoglobulin (pH4) for Intravenous Injection Sales Share by Manufacturers
Table United States Human Immunoglobulin (pH4) for Intravenous Injection Revenue by Manufacturers (2015 and 2016)
Table United States Human Immunoglobulin (pH4) for Intravenous Injection Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Human Immunoglobulin (pH4) for Intravenous Injection Revenue Share by Manufacturers
Table 2016 United States Human Immunoglobulin (pH4) for Intravenous Injection Revenue Share by Manufacturers
Table United States Market Human Immunoglobulin (pH4) for Intravenous Injection Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Human Immunoglobulin (pH4) for Intravenous Injection Average Price of Key Manufacturers in 2015
Figure Human Immunoglobulin (pH4) for Intravenous Injection Market Share of Top 3 Manufacturers
Figure Human Immunoglobulin (pH4) for Intravenous Injection Market Share of Top 5 Manufacturers
Table United States Human Immunoglobulin (pH4) for Intravenous Injection Sales by Type (2011-2016)
Table United States Human Immunoglobulin (pH4) for Intravenous Injection Sales Share by Type (2011-2016)
Figure United States Human Immunoglobulin (pH4) for Intravenous Injection Sales Market Share by Type in 2015
Table United States Human Immunoglobulin (pH4) for Intravenous Injection Revenue and Market Share by Type (2011-2016)
Table United States Human Immunoglobulin (pH4) for Intravenous Injection Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Human Immunoglobulin (pH4) for Intravenous Injection by Type (2011-2016)
Table United States Human Immunoglobulin (pH4) for Intravenous Injection Price by Type (2011-2016)
Figure United States Human Immunoglobulin (pH4) for Intravenous Injection Sales Growth Rate by Type (2011-2016)
Table United States Human Immunoglobulin (pH4) for Intravenous Injection Sales by Application (2011-2016)
Table United States Human Immunoglobulin (pH4) for Intravenous Injection Sales Market Share by Application (2011-2016)
Figure United States Human Immunoglobulin (pH4) for Intravenous Injection Sales Market Share by Application in 2015
Table United States Human Immunoglobulin (pH4) for Intravenous Injection Sales Growth Rate by Application (2011-2016)
Figure United States Human Immunoglobulin (pH4) for Intravenous Injection Sales Growth Rate by Application (2011-2016)
Table Baxter Basic Information List
Table Baxter Human Immunoglobulin (pH4) for Intravenous Injection Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Baxter Human Immunoglobulin (pH4) for Intravenous Injection Sales Market Share (2011-2016)
Table CSL Basic Information List
Table CSL Human Immunoglobulin (pH4) for Intravenous Injection Sales, Revenue, Price and Gross Margin (2011-2016)
Table CSL Human Immunoglobulin (pH4) for Intravenous Injection Sales Market Share (2011-2016)
Table Bayer Basic Information List
Table Bayer Human Immunoglobulin (pH4) for Intravenous Injection Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bayer Human Immunoglobulin (pH4) for Intravenous Injection Sales Market Share (2011-2016)
Table Grifols Basic Information List
Table Grifols Human Immunoglobulin (pH4) for Intravenous Injection Sales, Revenue, Price and Gross Margin (2011-2016)
Table Grifols Human Immunoglobulin (pH4) for Intravenous Injection Sales Market Share (2011-2016)
Table Octapharma Basic Information List
Table Octapharma Human Immunoglobulin (pH4) for Intravenous Injection Sales, Revenue, Price and Gross Margin (2011-2016)
Table Octapharma Human Immunoglobulin (pH4) for Intravenous Injection Sales Market Share (2011-2016)
Table Shanghai RAAS Basic Information List
Table Shanghai RAAS Human Immunoglobulin (pH4) for Intravenous Injection Sales, Revenue, Price and Gross Margin (2011-2016)
Table Shanghai RAAS Human Immunoglobulin (pH4) for Intravenous Injection Sales Market Share (2011-2016)
Table Hualan Biological Basic Information List
Table Hualan Biological Human Immunoglobulin (pH4) for Intravenous Injection Sales, Revenue, Price and Gross Margin (2011-2016)
Table Hualan Biological Human Immunoglobulin (pH4) for Intravenous Injection Sales Market Share (2011-2016)
Table China Biologic Basic Information List
Table China Biologic Human Immunoglobulin (pH4) for Intravenous Injection Sales, Revenue, Price and Gross Margin (2011-2016)
Table China Biologic Human Immunoglobulin (pH4) for Intravenous Injection Sales Market Share (2011-2016)
Table Tiantan Biologic Basic Information List
Table Tiantan Biologic Human Immunoglobulin (pH4) for Intravenous Injection Sales, Revenue, Price and Gross Margin (2011-2016)
Table Tiantan Biologic Human Immunoglobulin (pH4) for Intravenous Injection Sales Market Share (2011-2016)
Table Shuanglin Bio-pharmacy Basic Information List
Table Shuanglin Bio-pharmacy Human Immunoglobulin (pH4) for Intravenous Injection Sales, Revenue, Price and Gross Margin (2011-2016)
Table Shuanglin Bio-pharmacy Human Immunoglobulin (pH4) for Intravenous Injection Sales Market Share (2011-2016)
Table Sichuan Yuanda Shuyang Basic Information List
Table Sichuan Yuanda Shuyang Human Immunoglobulin (pH4) for Intravenous Injection Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sichuan Yuanda Shuyang Human Immunoglobulin (pH4) for Intravenous Injection Sales Market Share (2011-2016)
Table Boya Bio-pharmaceutical Basic Information List
Table Boya Bio-pharmaceutical Human Immunoglobulin (pH4) for Intravenous Injection Sales, Revenue, Price and Gross Margin (2011-2016)
Table Boya Bio-pharmaceutical Human Immunoglobulin (pH4) for Intravenous Injection Sales Market Share (2011-2016)
Table Shanghai Institute of Biological Basic Information List
Table Shanghai Institute of Biological Human Immunoglobulin (pH4) for Intravenous Injection Sales, Revenue, Price and Gross Margin (2011-2016)
Table Shanghai Institute of Biological Human Immunoglobulin (pH4) for Intravenous Injection Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Human Immunoglobulin (pH4) for Intravenous Injection
Figure Manufacturing Process Analysis of Human Immunoglobulin (pH4) for Intravenous Injection
Figure Human Immunoglobulin (pH4) for Intravenous Injection Industrial Chain Analysis
Table Raw Materials Sources of Human Immunoglobulin (pH4) for Intravenous Injection Major Manufacturers in 2015
Table Major Buyers of Human Immunoglobulin (pH4) for Intravenous Injection
Table Distributors/Traders List
Figure United States Human Immunoglobulin (pH4) for Intravenous Injection Production and Growth Rate Forecast (2016-2021)
Figure United States Human Immunoglobulin (pH4) for Intravenous Injection Revenue and Growth Rate Forecast (2016-2021)
Table United States Human Immunoglobulin (pH4) for Intravenous Injection Production Forecast by Type (2016-2021)
Table United States Human Immunoglobulin (pH4) for Intravenous Injection Consumption Forecast by Application (2016-2021)